Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
Share Price: 760.00p Change Today: 1.50p  Market Cap: 2,936.74m

BTG Overview

BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.

1 Day Chart

6 Month Chart

BTG Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-13 233.70 24.10 14.50p 24.6 0.9 +27% n/a 0.0%
31-Mar-14 290.50 33.30 14.50p 37.4 n/a n/a n/a 0.0%
31-Mar-15 367.80 26.70 15.70p 45.5 5.7 +8% n/a 0.0%
31-Mar-16 447.50 57.50 21.90p 28.4 0.7 +40% n/a 0.0%
31-Mar-17 570.50 31.60 23.10p 25.4 4.2 +6% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

BTG Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-18 612.65 154.90 30.43p 24.9 0.8 +32% n/a 0.0%
31-Mar-19 638.49 166.74 32.78p 23.1 3.0 +8% n/a 0.0%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

BTG Company Announcements

Interventional Medicine Seminar 07-Dec-2017 07:00 RNS
Total Voting Rights 01-Dec-2017 09:59 RNS
Appointment of Non-executive Director 27-Nov-2017 07:00 RNS

Latest BTG Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.


Price Data

Currency UK Pounds
Share Price 760.00p
Change Today 1.50p
% Change 0.20 %
Volume 409
14-Dec-17 Close 758.50p
Shares Issued 386.41m
Market Cap 2,936.74m
Year End 31-Mar-17

What The Brokers Say

Strong Buy 6
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 9
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BTG Dividends

No dividends found

Trades for 15-Dec-2017

Time Volume / Share Price
08:05 392 @ 760.00p
08:00 17 @ 757.50p

BTG Key Personnel

CEO Dame Pamela Louise Makin
CFO Rolf Soderstrom
Chair Garry Watts